← Back to Search

Pomegranate Tablet for Enlarged Prostate

Phase 1
Waitlist Available
Led By Leland Ronningen, MD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time points in which data is collected are initial visit, two weeks, four weeks, and 2, 4, 6, 8, 10, and 12 months.
Awards & highlights

Study Summary

To determine whether pomegranate tablets have a therapeutic effect on Benign Prostatic Hyperplasia.

Eligible Conditions
  • Enlarged Prostate

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time points in which data is collected are initial visit, two weeks, four weeks, and 2, 4, 6, 8, 10, and 12 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and time points in which data is collected are initial visit, two weeks, four weeks, and 2, 4, 6, 8, 10, and 12 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patients w/ BPH symptoms will be followed w/ AUA symptom questionnaires & exams; in addition, urinary flow rate & post void residual checks will be done to determine whether patients on pomegranate tablets have a reduction in symptoms.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Pomegranate TabletExperimental Treatment1 Intervention
Group II: Placebo TabletPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Pomegranate HealthIndustry Sponsor
University of California, IrvineLead Sponsor
544 Previous Clinical Trials
1,923,023 Total Patients Enrolled
Jarrow PharmaceuticalsUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025